Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01058499 · ClinicalTrials.gov registry record · Phase 1
Mindfulness Based Stress Reduction in COPD
A Phase 1 study of Chronic Obstructive Pulmonary Disease and COPD, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01058499 is a Phase 1 study of Chronic Obstructive Pulmonary Disease and COPD that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 1,754-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01058499, a Phase 1 study of Chronic Obstructive Pulmonary Disease and COPD, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to test the efficacy of a Mindfulness Based Stress Reduction program in COPD on quality of life, dyspnea, daily physical activity and mindfulness during daily life.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness Based Stress Reduction Program (MBSR)
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01058499
The ClinicalTrials.gov registry entry for NCT01058499 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,754-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness Based Stress Reduction Program (MBSR) is the first listed.
NCT01058499 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01058499 about?
NCT01058499 is a clinical study titled "Mindfulness Based Stress Reduction in COPD". The objective of this study is to test the efficacy of a Mindfulness Based Stress Reduction program in COPD on quality of life, dyspnea, daily physical activity and mindfulness during daily life.
What is the current status of trial NCT01058499?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2010-02. Estimated completion is 2010-12.
What conditions does trial NCT01058499 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease, COPD.
What interventions are being tested in trial NCT01058499?
The interventions under investigation include: Mindfulness Based Stress Reduction Program (MBSR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01058499?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01058499 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of Semaglutide in Advanced Lung Disease
RECRUITING · Phase 1
-
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
RECRUITING · Phase 1
-
Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy
RECRUITING · Phase 1
-
: Vascular Function in Health and Disease
RECRUITING · Phase 1
-
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
COMPLETED · Phase 1
-
Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disease (COPD)
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.